Back to front
Section

Business

Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.

Eli Lilly’s LLY gets boost as analysts cite fresh retatrutide trial results and a wider push into next-gen obesity drugs
The Apex Times

THE APEX TIMES

More Stories